))
Untangling PANDAS & PANS: Conversations about Infection-Associated, Immune-Mediated Neuropsychiatric Disorders
«
»
S1 E1:The Immunological Basis of Eating Disorders and PANDAS/PANS
Manage episode 411124116 series 3567249
Innehåll tillhandahållet av Susan Newman Manfull, PhD and Susan Newman Manfull. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Susan Newman Manfull, PhD and Susan Newman Manfull eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Lauren Breithaupt, PhD, Assistant Professor of Psychiatry, based in the Eating Disorders Clinical and Research Program at Massachusetts General Hospital, will discuss her cutting-edge research about the immunological basis of eating disorders and PANDAS and PANS.
After briefly describing her work on eating disorders, she talks about her new research on PANDAS and PANS. Entitled “Using a Machine Learning Approach to Identify Immune Biomarkers Associated with PANS/PANDAS,” Dr. Breithaupt’s latest work will focus on PANDAS/PANS, OCD, and restrictive eating disorders (R-ED) with the specific goal of identifying a disease specific biomarker for PANDAS/PANS. This would be a huge step forward for this neuroimmune disorder as, currently, there are no such biomarkers.
To carry out this study, Dr. Breithaupt has established what is believed to be the largest protein library of PANS/PANDAS symptoms to date. The library includes proteins expression levels of 476 adolescents diagnosed with the disorders representing overlapping PANS/PANDAS symptoms -- OCD, restrictive-eating disorders -- as well as individuals with PANS/PANDAS and age matched healthy controls. The goal is to identify disease specific biomarkers for each disorder using this very large and comprehensive data set of patients with symptoms indicative of each disorder.
Identifying protein biomarkers is important for diagnosis, the identification of novel targets for drug development, and to further understand the biological underpinnings of these disorders. Very importantly, the results of this proposed study will serve as pilot data for larger NIMH grants.
Dr. Breithaupt’s current research is funded by The Alex Manfull Fund with generous contributions from The Louisa Adelynn Johnson Fund for Complex Disease and Neuroimmune Foundation.
Recorded March 28, 2024
Disclaimer: The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent.
Credits: Music by Kingsley Durant from his "Convertible" album
To learn more about PANDAS and PANS and The Alex Manfull Fund, visit our website: TheAlexManfullFund.org
Follow us on:
Facebook
Instagram
LinkedIn
11 episoder
Dela
